Nordic Biomarker is a Swedish original manufacturer of advanced reagents, calibrators and controls for coagulation and clinical chemistry analyzers. The products are sold on OEM basis or under Nordic Biomarker’s CE-marked Medirox brand, and delivered to clients around the world.
Our reason to partner up
- Unique and competitive position in a growing market with high stickiness and barriers to entry
- Clear sustainability perspective of supporting access to good health, offering high-quality products
- Proven historical track record.
What we add
- Experience in building global niche market leaders
- Financial support and willingness to make investments in organization to enable future growth
- Identification and sourcing of suitable add-on acquisitions
Fund: PCI VII
Year of acquisition: 2022
Number of employees: c. 85
Revenue 2022: c. 14 MEUR
Related information:
Procuritas partners with Nordic Biomarker
